摘要
参麦注射液是由人参、麦冬中药复方提取精制而成的注射液。临床观察治疗无症状性冠心病26例，结果表明，参麦注射液能明显改善无症状性冠心病的ST-T改变，其作用优于对照药物消心痛，诊疗期间未见毒副作用。
Shenmai injection, composed of Radix Ginseng, Radix Ophiopogonis, etc. is clinicallyused for the treatment of symptomless coronary heart disease on 26 cases. As a result, itcould improve the ST-T change of symptomless coronary heart disease. This action is superior to that of the control drug isosorbide nitrate. No toxicity and side-effect are observed during treatment course.
出处
《中成药》
CAS
CSCD
1998年第6期27-28,共2页
Chinese Traditional Patent Medicine
关键词
参麦注射液
无症状性冠心病
中医药治疗
疗效
Shenmai Injection,symptomless coronary heart disease,clinical application
